Liposomes recognized as versatile agents for delivering drugs, have garnered considerable attention within the realm of pharmaceutical science. Nevertheless, their stability and performance within living organisms are subject to substantial influence by the presence of plasma proteins.
Interaction Mechanisms
The interplay between liposomes and plasma proteins, notably albumin, immunoglobulins, and lipoproteins, takes place through diverse mechanisms. The bonding of these proteins to the surface of liposomes triggers alterations in the physical and chemical attributes of the liposomes. These changes have a direct impact on their stability, duration within the bloodstream, and distribution throughout the body. Grasping the intricacies of these interactions becomes pivotal in foreseeing the trajectory of liposomes in the circulatory system and their subsequent engagement with specific cells or tissues.
Effects of Protein Corona on the Intracellular Performance of Liposomes
Liposomes hailed as prominent nano-carriers of drugs, showcase benefits such as superior drug loading efficiency, a broad spectrum for drug compatibility, and exceptional biocompatibility. Their modification with targeting elements presents a promising avenue for achieving targeted drug delivery. Therefore, prolonging their presence in the bloodstream, enhancing their accumulation in target tissues, and minimizing accumulation in healthy tissues to curtail toxicity all emerge as critical considerations in the design of liposomal drugs. It is imperative to grasp the formation and composition of the protein corona and its ramifications on the internal functioning of liposomes.
Impact of Protein Corona Formation on Liposomal Pharmacokinetics
Protein corona formation rapidly alters the surface properties of nanoparticles, affecting their in vivo performance. Liposomes, as exogenous substances, are recognized by the mononuclear phagocytic system (MPS), leading to rapid clearance and increased accumulation in the liver. Understanding the impact of protein corona formation on liposomal pharmacokinetics helps predict their safety and efficacy.
The binding pattern of liposomes with plasma proteins is a critical factor affecting their recognition by the MPS. Non-opsonin proteins like serum albumin and apolipoprotein J (Apo J) reduce the interaction of liposomes with cell membranes and uptake by macrophages. Conversely, opsonization by complement and immunoglobulins accelerates liposome recognition by macrophages, leading to their rapid clearance. Proteins such as IgG, IgA, IgM, C3, C4, C5, fibronectin, and C-reactive protein enhance liposome recognition by macrophages. f
Protein corona formation also alters the phagocytic mechanisms of macrophages, mediated by scavenger receptors recognizing proteins such as fibrinogen, immunoglobulins, and complement components. Understanding the impact of protein corona formation on liposome tissue distribution is crucial in avoiding excessive accumulation in the liver and spleen.
Impact of Protein Corona Formation on Liposome Compatibility and Immunological Safety
While liposomes themselves are generally considered to provoke a minimal immune response, their structural similarities to viruses render them susceptible to detection by the innate immune system, potentially triggering hyperactive immune reactions. Notably, the assimilation of crucial elements like C3 from the plasma can ignite processes such as coagulation and complement activation, ultimately amplifying the likelihood of hyperactive immune responses. This is a critical concern, as the development of a protein corona on the liposomal surface can stimulate the internalization of liposomes by dendritic cells, amplifying antibody production and thereby intensifying their immunogenicity, thus escalating the potential for hyperactive immune reactions.
Moreover, the implications of the protein corona's formation extend beyond immune responses, affecting a range of physiological processes such as platelet activation, red blood cell lysis, and the uptake of liposomes by endothelial cells. Notably, the use of positively charged liposomes presents a strategy for mitigating cellular damage by selectively attracting highly negatively charged plasma proteins, thereby diminishing toxicity and adverse effects.
Impact of Protein Corona Formation on Liposomal Targeting Efficiency
The effectiveness of targeted liposomal drug delivery hinges significantly on the interplay between the protein corona and liposomal performance. This dynamic interaction can either impede or facilitate the binding of targeting molecules to receptors or antigens, directly impacting the accuracy of liposomal targeting mechanisms. Comprehending the influence of plasma protein composition and characteristics on liposomal targeting efficiency is imperative for ensuring the success of targeted liposomal drug delivery.
Moreover, the interplay of the protein corona has significant sway over the rates of discharge and disintegration of liposomes, thus molding their drug delivery dynamics. Consider the instance of temperature-sensitive liposomes; the presence of a protein corona might induce a sluggish and incomplete liberation of drugs within the biological system. Conversely, the removal of this protein corona could expedite the rapid and comprehensive release of the encapsulated drug from the liposomes.
The intricate regulation of liposomal functionality by plasma proteins constitutes a multifaceted phenomenon that profoundly impacts the trajectory and effectiveness of liposomal drug conveyance systems. Through a comprehensive grasp of the mechanisms governing protein-liposome interactions, researchers can devise tactical approaches to enhance the in vivo conduct of liposomal formulations and development of more effective and targeted therapeutic interventions for various diseases.
References
- Li H.; et al. Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy. Journal of Controlled Release. 2023, 355: 593-603.
- Giulimondi F.; et al. Interplay of protein corona and immune cells controls blood residency of liposomes. Nature Communications. 2019, 10(1): 3686.
.
